Long-term safety and erythroid response with luspatercept treatment in patients with β-thalassemia

Long-term safety and erythroid response with luspatercept treatment in patients with β-thalassemia

Background: β-thalassemia is a hereditary blood disorder resulting in ineffective erythropoiesis and anemia. Management of anemia with regular blood transfusions is associated with complications including iron overload. Here, we report long-term safety and efficacy results of the first clinical stud...

Full description

Bibliographic Details
Main Authors: Antonio Piga, Filomena Longo, Maria Rita Gamberini, Ersi Voskaridou, Paolo Ricchi, Vincenzo Caruso, Antonello Pietrangelo, Xiaosha Zhang, Jeevan K. Shetty, Kenneth M. Attie, Immacolata Tartaglione
Format: Article
Language:English
Published: SAGE Publishing 2022-12-01
Series:Therapeutic Advances in Hematology
Online Access:https://doi.org/10.1177/20406207221134404

Internet

https://doi.org/10.1177/20406207221134404

Similar Items